Government Enforcement and Health Care Attorneys Examine Key Compliance Measures for Drug and Device Companies Creating Global Compliance Programs

In The News
April 5, 2017

In a Q&A titled “Helping piece together the life sciences puzzle,” health care counsel Alison Fethke discusses critical systems and controls pharmaceutical and medical device manufacturers should consider when creating integrated global compliance programs that can be presented to the U.S. Department of Justice and Securities and Exchange Commission. The article was published in the Chicago Daily Law Bulletin on April 3, 2017.